Pass the ACRP Certified Professional ACRP-CP Questions and answers with ExamsMirror

If the IRB/IEC has a policy that does not permit social media recruiting, the site must adhere to these regulations. Proceeding with a method not approved by the IRB/IEC would violate compliance requirements, so declining the study is the correct course of action.

The answer aligns with IRB/IEC regulations that prioritize ethical and compliant recruitment methods.

"Sites must follow the recruitment methods approved by their IRB/IEC to maintain compliance and ethical standards."

Objectives:

Adhering to ethical recruitment practices.

Maintaining compliance with IRB/IEC policies.

An audit is a systematic and independent examination of trial-related activities and documents. Its purpose is to determine whether the study was conducted in compliance with the protocol, GCP, and regulatory requirements. Audits are usually performed by the sponsor or an independent auditor and focus on evaluating data integrity and trial conduct.

GCP guidelines define an audit as a thorough examination to ensure adherence to protocol and regulatory requirements.

"An audit is a systematic and independent examination of trial-related activities to verify compliance with the protocol and regulatory standards."

Objectives:

Ensure compliance and data integrity.

Identify any gaps in trial conduct.

Interim analysis should be reviewed by independent qualified individuals, such as members of a Data Safety Monitoring Board (DSMB) or Independent Data Monitoring Committee (IDMC). This ensures that the analysis is unbiased and that decisions regarding continuation, modification, or termination of the trial are made objectively.

GCP guidelines emphasize that interim data should be reviewed by an independent committee to prevent bias and ensure participant safety.

"Interim analyses should be conducted by independent experts to maintain objectivity and safeguard trial integrity."

Objectives:

Maintain impartiality during interim analysis.

Ensure unbiased decision-making regarding trial continuation.

The primary factor in determining whether a protocol deviation should be reported to the IRB/IEC is whether the deviation impacts participant safety or the integrity of the study data. Any deviation that could pose a risk to participants must be reported promptly to ensure ongoing ethical oversight.

GCP guidelines mandate reporting of any protocol deviations that affect safety or data integrity to the IRB/IEC.

"Protocol deviations that impact the safety of participants or the integrity of the study must be reported to the IRB/IEC."

Objectives:

Maintain participant safety.

Ensure regulatory compliance through prompt reporting.

The purpose of statistical analysis in a clinical trial is to evaluate whether the data supports rejecting the null hypothesis, which typically states that there is no effect or difference. If the analysis finds a statistically significant result, the null hypothesis is rejected, indicating that the investigational drug has an effect on cholesterol levels.

The answer follows statistical principles in clinical trials, where the null hypothesis is rejected if evidence shows a significant difference or effect.

"In hypothesis testing, rejecting the null hypothesis indicates that the treatment effect is statistically significant."

Objectives:

Understand hypothesis testing in clinical research.

Interpret statistical outcomes accurately.

In a clinical trial aimed at assessing whether an IP prevents disease recurrence, the primary endpoint would typically be the "time to occurrence of symptoms" indicating a relapse or recurrence. This endpoint directly measures the IP’s effectiveness in prolonging the symptom-free period.

This answer follows the GCP guideline, which states that primary endpoints should directly reflect the trial's objectives, particularly when evaluating recurrence prevention.

"In trials evaluating recurrence prevention, the primary endpoint should measure the time until recurrence of the target symptoms or condition."

Objectives:

Assess the efficacy of IP in preventing disease recurrence.

Accurately measure the time to recurrence as a primary endpoint.

For cognitively impaired participants who may not fully understand the informed consent process, a legally acceptable representative (LAR) must be involved. This ensures that the participant's rights and interests are protected and that consent is obtained ethically and legally.

GCP guidelines mandate that, in cases where participants are unable to provide informed consent, an LAR must be involved to make decisions on their behalf.

"When a participant is cognitively impaired, informed consent must be obtained from a legally acceptable representative to ensure ethical participation."

Objectives:

Safeguard the rights of vulnerable populations.

Maintain ethical standards in the consent process.